TGF-β1 activates two distinct type I receptors in neurons: Implications for neuronal NF-κB signaling

Journal of Cell Biology

Volumn 168, Issue 7, 2005, Pages 1077-1086

  König, Hans Georg ^a   Kögel, Donat ^a   Rami, Abdelhaq ^a   Prehn, Jochen H M ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN LIKE KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CYTOPROTECTION; DNA-BINDING PROTEINS; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PC12 CELLS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 16844381310     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200407027     Document Type: Article

References (62)

1. Angley, C., M. Kumar, K.J. Dinsio, A.K. Hall, and R.E. Siegel. 2003. Signaling by bone morphogenetic proteins and Smadl modulates the postnatal differentiation of cerebellar cells. J. Neurosci. 23:260-268.
2. Arsura, M., M. Wu, and G.E. Sonenshein. 1996. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity. 5:31-40.
3. Attisano, L., J. Carcamo, F. Ventura, P.M. Weis, J. Massague, and J.L. Wrana. 1993. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:671-680.
4. Ayata, C., G. Ayata, H. Hara, R.T. Matthews, M.F. Beal, R.J. Ferrante, M. Endres, A. Kim, R.H. Christie, C. Waeber, et al. 1997. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J. Neurosci. 17:6908-6917.
5. Barrett, G.L., and P.F. Bartlett. 1994. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc. Natl. Acad. Sci. USA. 91:6501-6505.
6. Bhakar, A.L., L.L. Tannis, C. Zeindler, M.P. Russo, C. Jobin, D.S. Park, S. MacPherson, and P.A. Barker. 2002. Constitutive nuclear factor-kappa B activity is required for central neuron survival. J. Neurosci 22:8466-8475.
7. Bitzer, M., G. von Gersdorff, D. Liang, A. Dominguez-Rosales, A.A. Beg, M. Rojkind, and E.P. Bottinger. 2000. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14:187-197.
8. Bottner, M., K. Unsicker, and C. Suter-Crazzolara. 1996. Expression of TGF-beta type II receptor mRNA in the CNS. Neuroreport. 7:2903-2907.
9. Brionne, T.C., I. Tesseur, E. Masliah, and T. Wyss-Coray. 2003. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron. 40:1133-1145.
10. Bui, N.T., A. Livolsi, J.F. Peyron, and J.H. Prehn. 2001. Activation of nuclear factor κB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα. J. Cell Biol. 152:753-764.
11. Buisson, A., O. Nicole, F. Docagne, H. Sartelet, E.T. Mackenzie, and D. Vivien. 1998. Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J. 12:1683-1691.
12. Carter, B.D., C. Kaltschmidt, B. Kaltschmidt, N. Offenhauser, R. Bohm-Matthaei, P.A. Baeuerle, and Y.A. Barde. 1996. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science. 272:542-545.
13. Chen, Y.G., and J. Massague. 1999. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J. Biol. Chem. 274:3672-3677.
14. Dawson, V.L., T.M. Dawson, E.D. London, D.S. Bredt, and S.H. Snyder. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:6368-6371.
15. de Luca, A., M. Weller, and A. Fontana. 1996. TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J. Neurosci. 16:4174-4185.
16. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
17. Di Guglielmo, G.M., C. Le Roy, A.F. Goodfellow, and J.L. Wrana. 2003. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 5:410-421.
18. Flanders, K.C., G. Ludecke, S. Engels, D.S. Cissel, A.B. Roberts, P. Kondaiah, R. Lafyatis, M.B. Sporn, and K. Unsicker. 1991. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development. 113:183-191.
19. Flanders, K.C., R.F. Ren, and C.F. Lippa. 1998. Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54:71-85.
20. Franzen, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.H. Heldin, and K. Miyazono. 1993. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell. 75:681-692.
21. Ganchi, P.A., S.C. Sun, W.C. Greene, and D.W. Ballard. 1993. A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization. Mol. Cell. Biol. 13:7826-7835.
22. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell. 109(Suppl):S81-S96.
23. Goumans, M.J., G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke. 2002. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21:1743-1753.
24. Goumans, M.J., G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, C. Mummery, S. Karlsson, and P. ten Dijke. 2003. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell. 12:817-828.
25. Hata, A., G. Lagna, J. Massague, and A. Hemmati-Brivanlou. 1998. Smad6 inhibits BMP/Smadl signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:186-197.
26. Henrich-Noack, P., J.H. Prehn, and J. Krieglstein. 1996. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke. 27:1609-1614.
27. Hoffmann, A., T.H. Leung, and D. Baltimore. 2003. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 22:5530-5539.
28. Inman, G.J., F.J. Nicolas, J.F. Callahan, J.D. Harling, L.M. Gaster, A.D. Reith, N.J. Laping, and C.S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65-74.
29. Kaltschmidt, B., and C. Kaltschmidt. 2001. DNA array analysis of the developing rat cerebellum: transforming growth factor-beta2 inhibits constitutively activated NF-kappaB in granule neurons. Mech. Dev. 101:11-19.
30. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P.A. Baeuerle. 1994. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14:3981-3992.
31. Kim, E.S., R.S. Kim, R.F. Ren, D.B. Hawver, and K.C. Flanders. 1998. Transforming growth factor-beta inhibits apoptosis induced by beta-amyloid peptide fragment 25-35 in cultured neuronal cells. Brain Res. Mol. Brain Res. 62:122-130.
32. Kögel, D., M. Peters, H.G. Konig, S.M. Hashemi, N.T. Bui, V. Arolt, M. Rothermundt, and J.H. Prehn. 2004. S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury. Neuroscience. 127:913-920.
33. Krieglstein, K., C. Suter-Crazzolara, W.H. Fischer, and K. Unsicker. 1995. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14:736-742.
34. Krieglstein, K., S. Richter, L. Farkas, N. Schuster, N. Dunker, R.W. Oppenheim, and K. Unsicker. 2000. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat. Neurosci. 3:1085-1090.
35. Lamouille, S., C. Mallet, J.J. Feige, and S. Bailly. 2002. Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood. 100:4495-4501.
36. Lee, H.H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA. 96:9136-9141.
37. Lei, S.Z., Z.H. Pan, S.K. Aggarwal, H.S. Chen, J. Hartman, N.J. Sucher, and S.A. Lipton. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron. 8:1087-1099.
38. Lindholm, D., E. Castren, R. Kiefer, F. Zafra, and H. Thoenen. 1992. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117:395-400.
39. Longa, E.Z., P.R. Weinstein, S. Carlson, and R. Cummins. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84-91.
40. Lutz, M., K. Krieglstein, S. Schmitt, P. ten Dijke, W. Sebald, A. Wizenmann, and P. Knaus. 2004. Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur. J. Biochem. 271:920-931.
41. Lux, A., L. Attisano, and D.A. Marchuk. 1999. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J. Biol. Chem. 274:9984-9992.
42. Mattson, M.P., C. Culmsee, Z. Yu, and S. Camandola. 2000. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74:443-456.
43. McNeill, H., C. Williams, J. Guan, M. Dragunow, P. Lawlor, E. Sirimanne, K. Nikolics, and P. Gluckman. 1994. Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport. 5:901-904.
44. Meffert, M.K., J.M. Chang, B.J. Wiltgen, M.S. Fanselow, and D. Baltimore. 2003. NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 6:1072-1078.
45. Meucci, O., and R.J. Miller. 1996. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J. Neurosci. 16:4080-4088.
46. Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C.H. Heldin, K. Miyazono, and P. ten Dijke. 1997. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:5353-5362.
47. Oberhammer, F.A., M. Pavelka, S. Sharma, R. Tiefenbacher, A.F. Purchio, W. Bursch, and R. Schulte-Hermann. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl. Acad. Sci. USA. 89:5408-5412.
48. Oh, S.P., T. Seki, K.A. Goss, T. Imamura, Y. Yi, P.K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2626-2631.
49. Prehn, J.H., and J. Krieglstein. 1994. Opposing effects of transforming growth factor-beta I on glutamate neurotoxicity. Neuroscience. 60:7-10.
50. Prehn, J.H., C. Backhauss, and J. Krieglstein. 1993a. Transforming growth factor-beta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13:521-525.
51. Prehn, J.H., B. Peruche, K. Unsicker, and J. Krieglstein. 1993b. Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60:1665-1672.
52. Prehn, J.H., V.P. Bindokas, C.J. Marcuccilli, S. Krajewski, J.C. Reed, and R.J. Miller. 1994. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA. 91:12599-12603.
53. Prehn, J.H., V.P. Bindokas, J. Jordan, M.F. Galindo, G.D. Ghadge, R.P. Roos, L.H. Boise, C.B. Thompson, S. Krajewski, J.C. Reed, and R.J. Miller. 1996. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49:319-328.
54. Ren, R.F., and K.C. Flanders. 1996. Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res. 732:16-24.
55. Ruocco, A., O. Nicole, F. Docagne, C. Ali, L. Chazalviel, S. Komesli, F. Yablonsky, S. Roussel, E.T. MacKenzie, D. Vivien, and A. Buisson. 1999. A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J. Cereb. Blood Flow Metab. 19:1345-1353.
56. Saccani, S., S. Pantano, and G. Natoli. 2003. Modulation of NF-kappaB activity by exchange of dimers. Mol. Cell. 11:1563-1574.
57. Shi, Y., and J. Massague. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:685-700.
58. Tamatani, M., Y.H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno, and M. Tohyama. 1999. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J. Biol. Chem. 274:8531-8538.
59. Wang, T. 2003. The 26S proteasome system in the signaling pathways of TGF-beta superfamily. Front. Biosci. 8:d1109-d1127.
60. Zhao, J., W. Shi, H. Chen, and D. Warburton. 2000. Smad7 and Smad6 differentially modulate transforming growth factor β-induced inhibition of embryonic lung morphogenesis. J. Biol. Chem. 275:23992-23997.
61. Zhu, Y., G.Y. Yang, B. Ahlemeyer, L. Pang, X.M. Che, C. Culmsee, S. Klumpp, and J. Krieglstein. 2002. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22:3898-3909.
62. Zhu, Y., C. Culmsee, S. Klumpp, and J. Krieglstein. 2004. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase 1,2 signaling pathways. Neuroscience. 123:897-906.